Welcome to Medications.com

NexMed Announces Presentation of Data at the 66th Annual Meeting ... - Trading Markets (press release)

NM100060 is a topical application of Lamisil(R) (terbinafine hydrochloride), formulated with terbinafine and NexMed's patented NexACT permeation enhancer, ...

http://www.tradingmarkets.com/.si... | Posted: Fri Feb 01 10:11:31 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea